Horizon Kinetics Holding Corporation (HKHC) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call April 2, 2025 4:15 PM ET. Company Participants. Murray Stahl - Chairman, CEO, Chief Investment O ...
PharmiWeb11h
CSL Behring and GKV-Spitzenverband Agree on Reimbursement Price for HEMGENIX® – Europe's First Gene Therapy for Haemophilia B
CSL Behring and the GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) have successfully concluded negotiations on the reimbursement price of HEMGENIX®. This agreement marks ...